SCHEMBL22356381

SCHEMBL22356381

C=CC(=O)Oc1ccc(Nc2nc(Nc3ccccc3)nc(Nc3ccc4cc(Nc5nc(Nc6ccccc6)nc(Nc6ccc(OC(=O)C=C)cc6)n5)ccc4c3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHOA P61586 1/20 0.51
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.48
HSP90AA1 P07900 1/20 0.48
EGFR P00533 8/20 0.47
BTK Q06187 5/20 0.47
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SNCA P37840 1/20 0.44
FLT3 P36888 1/20 0.43
BLK P51451 1/20 0.43
ITK Q08881 3/20 0.43
KCNH3 Q9ULD8 2/20 0.43
PIN1 Q13526 1/20 0.43
NPY5R Q15761 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ABL1 P00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356433 0.96 RHOA (0.54) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356391 0.96 RHOA (0.54) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356481 0.96 MAPT (0.51) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356446 0.96 MAPT (0.51) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356450 0.96 MAPT (0.51) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356482 0.96 MAPT (0.51) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356392 0.93 RHOA (0.49) RHOAEGFRBTKFLT3BLK
SCHEMBL22356478 0.90 RHOA (0.48) RHOAMAPTALDH1A1GAAHSP90AA1
SCHEMBL22356325 0.90 EGFR (0.49) MAPTALDH1A1GAAHSP90AA1EGFR
SCHEMBL22356451 0.89 RHOA (0.55) RHOAEGFRBTKITKKCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TREEEL CO., LTD (KR) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TYR, CRY2, CRY1 RHOA 3916/4885MAPT 820/4885ALDH1A1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.